Please login to the form below

Cephalon

This page shows the latest Cephalon news and features for those working in and with pharma, biotech and healthcare.

Lundbeck challenge to EC pay-for-delay ruling fails

Two other investigations - involving AstraZeneca/Nycomed and Teva/Cephalon - did not result in enforcement action by the Commission.

Latest news

US government probes Lilly and Merck over drug pricing

In July both AstraZeneca (AZ) and Cephalon settled an action brought by the US government which accused them of underpaying. ... AZ paid nearly $47m to settle the cases, with Cephalon stumping up $7.5m, and at the time the DoJ said it would "continue to
Teva hit with $1.2bn pay-for-delay fine

Israeli-based Teva has reached a settlement resolving the Commission's antitrust suit charging its subsidiary Cephalon, with illegally blocking generic competition to its blockbuster sleep-disorder drug Provigil (modafinil). ... As part of the settlement,
Teva slapped with $512m fine on pay-for-delay deal

Teva is paying $512m to settle a legal case against its subsidiary Cephalon used pay-for-delay tactics on its wakefulness drug Provigil (modafinil). ... cases. The lawsuit, originally filed in 2006 by drug wholesalers and retailers that buy directly from
EU hits Servier and generic firms with €428m 'pay-for-delay' fine

Meanwhile, antitrust investigators in the EU are still looking at possible collusion between Teva and Cephalon, which is now owned by the Israeli company, concerning narcolepsy treatment Provigil (modafinil), while a
Global biosimilars market “will see exponential growth”

Biosimilar companies can reduce their market access time by linking with other companies with expertise in biosimilars manufacturing and development, Sashidhar added, citing Teva's alliance with Cephalon and Lupin Pharmaceuticals'

More from news
Approximately 1 fully matching, plus 68 partially matching documents found.

Latest Intelligence

Pharma deals in May 2015

This has proved to be the case following Teva's purchase of Cephalon in May 2011 for $6.2bn which brought Provigil (modafinil for sleep disorders) into the portfolio.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Pfizer’s Elizabeth Barrett joins Novartis as its oncology head

Prior to her time with Pfizer, Barrett held roles with Cephalon andchief executive officer at Novartis, said: “Liz is a highly accomplished and recognised oncology and people leader with an impressive
Martin Reeves joins Oxford BioDynamics

His career to date has seen him hold positions such as head of business development, global branded products at Teva Pharmaceuticals, VP of business development and strategic planning at Cephalon and
Srdjan Stankovic joins Acadia Pharmaceuticals

Prior to this he worked at Teva as senior vice president and head of global clinical development following that company's acquisition of Cephalon, where he was senior vice president, worldwide
Bruce Peacock joins Dicerna from Ophthotech

of Cephalon and chief financial officer of Centocor.
Paul Blake joins Oxford BioMedica

His career includes senior managed roles at Cephalon and a senior VP position at SmithKline Beecham Pharmaceuticals, now GSK.

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments

Arsenic. Trisenox. Cephalon. Treatment of patients with. acute promyelocytic leukaemia. .

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Account Director: Competitive

Healthcare Senior Account Manager: Competitive

Healthcare Lead Copywriter: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Medical Editor: Competitive

Account Director – Creative Healthcare Communications: Competative

PMHub

Add my company

Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
Three ways AI will change healthcare in the next decade: Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...